Tolerability of palbociclib in younger and older patients with advanced breast cancer

IntroductionPalbociclib is a small-molecule cyclin-dependent kinase 4/6 inhibitor used to treat hormone receptor-positive, human epidermal growth factor receptor-2 negative advanced breast cancer. ...